Clinical trials
Adenocarcinoma of Lung trials in Belgium
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
13 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2002 | 1 |
| 2011 | 1 |
| 2012 | 2 |
| 2013 | 1 |
| 2015 | 1 |
| 2016 | 1 |
| 2017 | 1 |
| 2018 | 1 |
| 2022 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 8 |
| Terminated | 4 |
| Withdrawn | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Novartis Pharmaceuticals | 6 |
| European Organisation for Research and Treatment of Cancer - EORTC | 3 |
| Amgen | 1 |
| Gustave Roussy, Cancer Campus, Grand Paris | 1 |
| Janssen Research & Development, LLC | 1 |
| Spectrum Pharmaceuticals, Inc | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Adenocarcinoma of Lung | 13 |
| Carcinoma, Non-Small-Cell Lung | 11 |
| Lung Neoplasms | 11 |
| Adenocarcinoma, Bronchiolo-Alveolar | 2 |
| Triple Negative Breast Neoplasms | 2 |
| Adenocarcinoma | 1 |
| Breast Neoplasms | 1 |
| Carcinoma, Ductal | 1 |
| Carcinoma, Ovarian Epithelial | 1 |
| Cholangiocarcinoma | 1 |
Trials
Showing 1 to 13 of 13. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.